BenQ Medical Technology Corporation (TPEX:4116)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
40.00
-0.25 (-0.62%)
Sep 8, 2026, 1:30 PM CST

BenQ Medical Technology Financials Overview

Millions TWD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
5,4455,2544,7674,5434,3771,465
Revenue Growth
6.83%10.21%4.94%3.80%198.82%4.55%
Gross Profit
1,7681,6901,4481,3441,247512.28
Operating Income
340.72342.42333.02365.44350.2646.46
Net Income
117.6978.17104.83114.58180.2428.84
Earnings Per Share
2.631.752.342.564.020.65
EPS Growth
38.32%-25.21%-8.59%-36.32%521.20%-53.44%

Revenue by Segment

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Medical Services
4,5914,3873,7863,5323,352481.86
Adjustment and Elimination
-73.06-74.87-56.79-20.52-65.59-35.9
R&D and Manufacturing Department
927.1941.421,0391,0321,0901,019
Total
5,4455,2544,7674,5434,3771,465

Cash & Debt

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
958.861,1881,1461,1541,167419.19
Total Debt
1,9971,9891,9061,5721,117491.75
Net Cash (Debt)
-1,038-800.37-760.13-418.1550.19-72.55
Net Cash Growth
------
Net Cash Per Share
-23.15-17.87-16.96-9.331.12-1.62

Cash Flow & CapEx

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
404.12358.75222.22442.35482.84121.35
Capital Expenditures
-58.26-93.91-170.09-133.47-76.89-30.26
Free Cash Flow
345.86264.8452.14308.88405.9591.09
Free Cash Flow Growth
97.07%407.99%-83.12%-23.91%345.66%-20.84%

Margins

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
32.47%32.16%30.38%29.58%28.50%34.98%
Operating Margin
6.26%6.52%6.98%8.04%8.00%3.17%
Pretax Margin
7.65%6.37%6.91%6.83%7.21%4.22%
Profit Margin
2.16%1.49%2.20%2.52%4.12%1.97%
FCF Margin
6.35%5.04%1.09%6.80%9.28%6.22%

Dividends

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Dividend Per Share
2.0002.0001.6502.0002.1000.500
Dividend Per Share Growth
21.21%21.21%-17.50%-4.76%320.00%-50.00%
Dividend Yield
4.94%4.78%3.84%3.55%3.86%1.78%

Valuation

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
15.2125.1420.0724.8915.8251.30
Forward PE
-32.8332.8332.8332.8332.83
P/FCF Ratio
5.157.4240.359.237.0316.24
PS Ratio
0.330.370.440.630.651.01